Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 7;16(7):e64036.
doi: 10.7759/cureus.64036. eCollection 2024 Jul.

Characteristics and Prognostic Factors Associated With the Progression of Myopic Traction Maculopathy in Mexican Patients

Affiliations

Characteristics and Prognostic Factors Associated With the Progression of Myopic Traction Maculopathy in Mexican Patients

Mauricio Bayram-Suverza et al. Cureus. .

Abstract

Background In this study, the characteristics and prognostic factors associated with the progression of myopic traction maculopathy (MTM) were evaluated in a Mexican population. Methods This is a retrospective observational study that analyzed patients with MTM who underwent optical coherence tomography (OCT). Clinical-ocular information, the MTM classification, and initial and final visual acuity (VA) were recorded. Results In total, 101 eyes of 84 patients (mean age 63.5 ± 10.7 years) were included (88.1% female and 11.9% male). The mean spherical equivalent was -16.8 ± 6.4 D, axial length was 29.6 ± 2.1 mm, and mean initial VA was 0.8 ± 0.5 logMAR. The mean follow-up time was 25.7 ± 27.6 months. The change in final VA from diagnosis to the last follow-up was +0.1 (0.2) (p = 0.001). Overall, 24.8% of patients progressed, 72.3% did not progress, and 3% showed regression. The patient-year progression rate was 0.20 ± 0.44. Factors associated with progression were initial logMAR VA (p= 0.012) and staphyloma (p= 0.001). Conclusions One in four patients with MTM progressed, and the patient-year progression rate was 0.5. The factors associated with disease progression were initial VA and the presence of staphyloma. The characteristics of Mexican patients with MTM are similar to those described in other populations.

Keywords: high myopia; myopia progression; myopic traction maculopathy; optical coherence tomography; visual acuity.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Local Ethics Committee of the “Fundación Hospital Nuestra Señora de la Luz” issued approval 2023R21B2. This study adhered to the guidelines of the Helsinki Declaration and had the approval of the local Ethics Committee of the hospital “Fundación Hospital Nuestra Señora de la Luz” and the Institutional Review Board. Approval code: 2023R21B2. All patients signed written informed consent for participation. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Visual acuity changes between diagnosis and the last follow-up (p < 0.001, paired t-test).
Note: the top of the bar represents the mean, and the whisker represents the standard deviation.
Figure 2
Figure 2. Disease progression and regression in patients with myopic traction maculopathy.
Figure 3
Figure 3. Representative case of myopic traction maculopathy (MTM) regression.
(a) During the basal examination of the patient, a macular optical coherence tomography showed macular detachment at stage 3A. (b) At the 12th month of follow-up, the macular detachment progressively collapsed. (c) After 30 months, the retina was reattached, and MTM was resolved; however, there was predominant macular atrophy of the external layers.
Figure 4
Figure 4. Representative case of myopic traction maculopathy (MTM) progression.
During the initial OCT examination (a), maculoschisis was found predominantly in the outer nuclear layer (stage 2A). After 36 months (b), the patient presented with maculoschisis in both the inner and outer retinal layers (stage 2A). After 42 months (c), the patient developed a lamellar macular hole and macular detachment, accompanied by the previous findings (stage 3B).

References

    1. The epidemics of myopia: aetiology and prevention. Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA. Prog Retin Eye Res. 2018;62:134–149. - PubMed
    1. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Fricke TR, Jong M, Naidoo KS, et al. Br J Ophthalmol. 2018;102:855–862. - PMC - PubMed
    1. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Holden BA, Fricke TR, Wilson DA, et al. Ophthalmology. 2016;123:1036–1042. - PubMed
    1. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Cotter SA, Varma R, Ying-Lai M, Azen SP, Klein R. Ophthalmology. 2006;113:1574–1582. - PubMed
    1. Battaglia Parodi M, Rabiolo A. Encyclopedia of Ophthalmology. Berlin, Heidelberg: Springer; 2018. Pathologic myopia.

LinkOut - more resources